Yuhan Corp (000100):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Yuhan Corp (000100) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10107
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Yuhan Corp (Yuhan) researches, develops, manufactures and markets pharmaceutical products. The company offers API’s and intermediates for antibiotic, antiviral, antifungal, anti-inflammatory, anti-diabetic, anti-HIV, anti-HCV, beta-lactase inhibitors, PEGlyated compounds and anti-histamines. It offers finished goods for the treatment of coronary artery disease, hypertension, hyperlipidemia, cerebral thrombosis and other diseases. The company provides custom synthesis services for other pharmaceutical and biopharmaceutical companies. It offers active pharmaceutical ingredients (API) and finished products in domestic and also international market. Yuhan operates R&D and manufacturing facilities in Seoul. It offers its products and services through its sales and distribution branches. Yuhan is headquartered in Seoul, South Korea.

Yuhan Corp (000100) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Yuhan Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Yuhan Corp, Medical Devices Deals, 2012 to YTD 2018 9
Yuhan Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Yuhan Corp, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Yuhan to Enter into Agreement with GC Pharma 11
Yuhan Enters into Agreement with Syntekabio 12
Sorrento Therapeutics Forms Joint Venture with Yuhan 13
Licensing Agreements 14
Janssen Biotech Enters into Licensing Agreement with Yuhan 14
Yuhan Enters into Licensing Agreement with Samsung Bioepis 15
Yuhan Enters into Licensing Agreement with Bioneer 16
Cevec Pharma Enters Into Licensing Agreement With Yuhan To Develop Therapeutic Proteins 17
Equity Offering 18
Sorrento Therapeutics Raises USD10 Million in Private Placement of Shares and Warrants 18
Acquisition 20
Yuhan Completes Acquisition Of 9.1% Stake In Hanall For US$27 Million 20
Yuhan Corp – Key Competitors 21
Yuhan Corp – Key Employees 22
Yuhan Corp – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Affiliate 24
Joint Venture 24
Recent Developments 25
Strategy And Business Planning 25
Nov 05, 2018: Yuhan licences lung cancer asset to Janssen in $1.25bn deal 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Yuhan Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Yuhan Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Yuhan Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Yuhan Corp, Medical Devices Deals, 2012 to YTD 2018 9
Yuhan Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Yuhan to Enter into Agreement with GC Pharma 11
Yuhan Enters into Agreement with Syntekabio 12
Sorrento Therapeutics Forms Joint Venture with Yuhan 13
Janssen Biotech Enters into Licensing Agreement with Yuhan 14
Yuhan Enters into Licensing Agreement with Samsung Bioepis 15
Yuhan Enters into Licensing Agreement with Bioneer 16
Cevec Pharma Enters Into Licensing Agreement With Yuhan To Develop Therapeutic Proteins 17
Sorrento Therapeutics Raises USD10 Million in Private Placement of Shares and Warrants 18
Yuhan Completes Acquisition Of 9.1% Stake In Hanall For US$27 Million 20
Yuhan Corp, Key Competitors 21
Yuhan Corp, Key Employees 22
Yuhan Corp, Other Locations 23
Yuhan Corp, Subsidiaries 23
Yuhan Corp, Affiliate 24
Yuhan Corp, Joint Venture 24

List of Figures
Yuhan Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Yuhan Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Yuhan Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Yuhan Corp (000100):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Marks and Spencer Group plc:企業の戦略・SWOT・財務情報
    Marks and Spencer Group plc - Strategy, SWOT and Corporate Finance Report Summary Marks and Spencer Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • SPAGO Nanomedical AB:医療機器:M&Aディール及び事業提携情報
    Summary Spago Nanomedical AB (Spago Nanomedical), formerly Spago Imaging AB is a research and development company that develops nanomedical products for the diagnosis and treatment of cancer. The company offers spagopix, a magnetic resonance imaging contrast agent to improve the visualization of sof …
  • WInco Foods LLC:企業の戦略・SWOT・財務情報
    WInco Foods LLC - Strategy, SWOT and Corporate Finance Report Summary WInco Foods LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Aimmune Therapeutics Inc (AIMT):企業の財務・戦略的SWOT分析
    Summary Aimmune Therapeutics Inc (Aimmune) formerly Allergen Research Corp is a clinical-stage biopharmaceutical company that develops proprietary product candidates for the treatment of peanut and other food allergies. The company’s lead product candidate AR101 is used to treat the peanut allergy. …
  • Nihon Chouzai Co Ltd (3341):企業の財務・戦略的SWOT分析
    Nihon Chouzai Co Ltd (3341) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Cable & Wireless Communications Ltd:企業の戦略的SWOT分析
    Cable & Wireless Communications Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Crossbeta Biosciences BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Crossbeta Biosciences BV (Crossbeta) is a biotech company that offers drug discovery programs for the treatment of misfolded protein diseases. The company develops drugs against Alzheimer’s, Parkinson’s, Huntington’s disease and ALS. It offers screening of oligomer-specific therapeutics and …
  • Toyota Motor Corporation:企業の戦略・SWOT・財務分析
    Toyota Motor Corporation - Strategy, SWOT and Corporate Finance Report Summary Toyota Motor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Strat Aero Plc (AERO):企業の財務・戦略的SWOT分析
    Summary Strat Aero Plc (Strat Aero) formally known as Remote Monitored Systems PLC is an aerospace company that offers management systems, training solutions and consultancy services to the Unmanned Aerial Vehicle (UAV) sector. The company’s services include survey and inspection services, surveilla …
  • HeartWare International Inc:企業の製品パイプライン分析2018
    Summary HeartWare International Inc (HeartWare), subsidiary of Medtronic Plc, is a medical device company that develops and manufactures ventricular assist devices and implantable heart pumps for the treatment of advanced heart failure. The company provides HeartWare Ventricular Assist System that c …
  • Digirad Corp (DRAD):医療機器:M&Aディール及び事業提携情報
    Summary Digirad Corp (Digirad) is a medical device company that provides mobile and on-site imaging solutions. The company provides camera products such as ergo, cardius x-ACT, cardius 2 XPO, corcam, quantumcam, cardius 3 XPO, and others. It provides diagnostic services such as nuclear cardiology, u …
  • Far Eastone Telecommunications Co Ltd (4904):企業の財務・戦略的SWOT分析
    Far Eastone Telecommunications Co Ltd (4904) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • I Grandi Viaggi Spa:企業の戦略・SWOT・財務分析
    I Grandi Viaggi Spa - Strategy, SWOT and Corporate Finance Report Summary I Grandi Viaggi Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • WuXi NextCODE Genomics:医療機器:M&Aディール及び事業提携情報
    Summary WuXi NextCODE Genomics USA Inc (WuXi NextCODE), a subsidiary of Wuxi Pharmatech (Cayman) Inc, is a genomic information company that offers competencies in generating, organizing, mining, sharing and applying genomic data. The company develops gene sequence analysis platform and database arch …
  • American National Insurance Co:戦略・SWOT・企業財務分析
    American National Insurance Co - Strategy, SWOT and Corporate Finance Report Summary American National Insurance Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Praxair, Inc.:企業の戦略・SWOT・財務分析
    Praxair, Inc. - Strategy, SWOT and Corporate Finance Report Summary Praxair, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Viridian Group Investments Ltd:企業の戦略的SWOT分析
    Viridian Group Investments Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Steel Authority of India Ltd:企業のM&A・事業提携・投資動向
    Steel Authority of India Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Steel Authority of India Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Origin Energy Limited:企業の戦略・SWOT・財務情報
    Origin Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Origin Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • NH Foods Ltd.:企業の戦略・SWOT・財務情報
    NH Foods Ltd. - Strategy, SWOT and Corporate Finance Report Summary NH Foods Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆